LADERX LLC
DURHAM, NC · CIK 0001970543 · Medtech · Private
Manganese-bisphosphonate MRI contrast agent for quantitative myocardial perfusion imaging
- Grants
- $300K
- 1 award
- Sector median: 1
- Raised
- $67K
- 2 Form D · Apr 2026
- 5 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $66,669 | |
| Federal grant | Department of Health and Human Services · Phase I · Manganese-based MRI contrast agent for quantitative myocardial perfusion imaging | $299,932 | |
| Private capital raised | Form D · SEC | $3,000,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 800 | Tulavi Therapeutics, Inc. | — | $13M |
| 801 | MICROVASCULAR TISSUES, INC. | — | $12M |
| 802 | THERAHEART INC. | — | $12M |
| 803 | LADERX LLC | — | $67K |
| 804 | AVEERA MEDICAL INC. | — | $8.8M |
| 805 | NANOCAN THERAPEUTICS CORPORATION | — | $6.2M |
| 806 | XCath, Inc. | — | $5.3M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Banks ClarkExecutive Officer
- Jeff ClarkExecutive Officer
- Christopher LascolaExecutive Officer
- Joseph McCaffreyExecutive Officer
- Lanty SmithExecutive Officer
- Margaret SmithExecutive Officer
Patents
- Metal Complexes With Bisphosphonate Or Pyrophosphate Useful As Imaging Agentsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.